Wolverine Trading’s Applied Therapeutics APLT Stock Holding History

Wolverine Trading’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$12.5K	Buy	+20,405	New	+$9.61K	﹤0.01%	5553
2025 Q1	–	Sell	-16,573	Closed	-$9.76K	–	4702
2024 Q4	$13.5K	Buy	+16,573	New	+$104K	﹤0.01%	5136
2024 Q3	–	Sell	-11,355	Closed	-$66.9K	–	4741
2024 Q2	$53K	Buy	+11,355	New	+$53.7K	﹤0.01%	4212
2024 Q1	–	Sell	-10,105	Closed	-$33.9K	–	4445
2023 Q4	$33.9K	Buy	+10,105	New	+$25.1K	﹤0.01%	4329

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wolverine Trading's APLT Position: Q3 2025 in Review

Wolverine Trading opened a new position in Applied Therapeutics (APLT) in Q3 2025: 20,405 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #5553 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in APLT as recently as Q4 2024.

Wolverine Trading first reported a position in APLT in Q4 2023 and has held it in 4 quarters since. The position peaked at $53K in Q2 2024. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

Wolverine Trading held 20,405 shares of Applied Therapeutics worth $12.5K as of Q3 2025.
Applied Therapeutics was a new Wolverine Trading position in Q3 2025.
Applied Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5553 holding.
Wolverine Trading first reported a position in Applied Therapeutics in Q4 2023 and has held it in 4 quarters since.
Wolverine Trading's Applied Therapeutics position peaked at $53K in Q2 2024.
70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.